Logo image of ACT.DE

ALZCHEM GROUP AG (ACT.DE) Stock Fundamental Analysis

Europe - FRA:ACT - DE000A2YNT30 - Common Stock

142.2 EUR
+2.4 (+1.72%)
Last: 9/17/2025, 5:29:40 PM
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to ACT. ACT was compared to 66 industry peers in the Chemicals industry. ACT scores excellent points on both the profitability and health parts. This is a solid base for a good stock. ACT is quite expensive at the moment. It does show a decent growth rate. With these ratings, ACT could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

ACT had positive earnings in the past year.
In the past year ACT had a positive cash flow from operations.
In the past 5 years ACT has always been profitable.
Of the past 5 years ACT 4 years had a positive operating cash flow.
ACT.DE Yearly Net Income VS EBIT VS OCF VS FCFACT.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M 100M

1.2 Ratios

ACT's Return On Assets of 10.48% is amongst the best of the industry. ACT outperforms 96.97% of its industry peers.
Looking at the Return On Equity, with a value of 26.66%, ACT belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
ACT's Return On Invested Capital of 13.72% is amongst the best of the industry. ACT outperforms 95.45% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ACT is significantly above the industry average of 6.62%.
The 3 year average ROIC (12.06%) for ACT is below the current ROIC(13.72%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 10.48%
ROE 26.66%
ROIC 13.72%
ROA(3y)8.81%
ROA(5y)7.86%
ROE(3y)22.87%
ROE(5y)25.91%
ROIC(3y)12.06%
ROIC(5y)10.63%
ACT.DE Yearly ROA, ROE, ROICACT.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

The Profit Margin of ACT (10.43%) is better than 84.85% of its industry peers.
In the last couple of years the Profit Margin of ACT has grown nicely.
ACT's Operating Margin of 15.34% is amongst the best of the industry. ACT outperforms 86.36% of its industry peers.
ACT's Operating Margin has improved in the last couple of years.
The Gross Margin of ACT (65.74%) is better than 96.97% of its industry peers.
In the last couple of years the Gross Margin of ACT has remained more or less at the same level.
Industry RankSector Rank
OM 15.34%
PM (TTM) 10.43%
GM 65.74%
OM growth 3Y17.53%
OM growth 5Y12.4%
PM growth 3Y14.29%
PM growth 5Y15.31%
GM growth 3Y2.01%
GM growth 5Y1.44%
ACT.DE Yearly Profit, Operating, Gross MarginsACT.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

9

2. Health

2.1 Basic Checks

ACT has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for ACT has been reduced compared to 1 year ago.
ACT has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, ACT has an improved debt to assets ratio.
ACT.DE Yearly Shares OutstandingACT.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ACT.DE Yearly Total Debt VS Total AssetsACT.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

An Altman-Z score of 4.76 indicates that ACT is not in any danger for bankruptcy at the moment.
The Altman-Z score of ACT (4.76) is better than 90.91% of its industry peers.
ACT has a debt to FCF ratio of 1.15. This is a very positive value and a sign of high solvency as it would only need 1.15 years to pay back of all of its debts.
ACT's Debt to FCF ratio of 1.15 is amongst the best of the industry. ACT outperforms 96.97% of its industry peers.
A Debt/Equity ratio of 0.18 indicates that ACT is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.18, ACT is in the better half of the industry, outperforming 74.24% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 1.15
Altman-Z 4.76
ROIC/WACC1.93
WACC7.1%
ACT.DE Yearly LT Debt VS Equity VS FCFACT.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 2.84 indicates that ACT has no problem at all paying its short term obligations.
With an excellent Current ratio value of 2.84, ACT belongs to the best of the industry, outperforming 81.82% of the companies in the same industry.
A Quick Ratio of 1.73 indicates that ACT should not have too much problems paying its short term obligations.
ACT has a better Quick ratio (1.73) than 77.27% of its industry peers.
Industry RankSector Rank
Current Ratio 2.84
Quick Ratio 1.73
ACT.DE Yearly Current Assets VS Current LiabilitesACT.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 25.65% over the past year.
ACT shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 24.60% yearly.
Looking at the last year, ACT shows a small growth in Revenue. The Revenue has grown by 1.03% in the last year.
Measured over the past years, ACT shows a quite strong growth in Revenue. The Revenue has been growing by 8.06% on average per year.
EPS 1Y (TTM)25.65%
EPS 3Y25.02%
EPS 5Y24.6%
EPS Q2Q%10.81%
Revenue 1Y (TTM)1.03%
Revenue growth 3Y9.49%
Revenue growth 5Y8.06%
Sales Q2Q%4.91%

3.2 Future

Based on estimates for the next years, ACT will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.50% on average per year.
The Revenue is expected to grow by 6.02% on average over the next years.
EPS Next Y16.75%
EPS Next 2Y15.49%
EPS Next 3Y18.99%
EPS Next 5Y19.5%
Revenue Next Year2.89%
Revenue Next 2Y6.03%
Revenue Next 3Y8.49%
Revenue Next 5Y6.02%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ACT.DE Yearly Revenue VS EstimatesACT.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M
ACT.DE Yearly EPS VS EstimatesACT.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8 10

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 24.90, the valuation of ACT can be described as rather expensive.
Compared to the rest of the industry, the Price/Earnings ratio of ACT is on the same level as its industry peers.
When comparing the Price/Earnings ratio of ACT to the average of the S&P500 Index (27.20), we can say ACT is valued inline with the index average.
A Price/Forward Earnings ratio of 20.93 indicates a rather expensive valuation of ACT.
ACT's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.70. ACT is around the same levels.
Industry RankSector Rank
PE 24.9
Fwd PE 20.93
ACT.DE Price Earnings VS Forward Price EarningsACT.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

ACT's Enterprise Value to EBITDA ratio is in line with the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as ACT.
Industry RankSector Rank
P/FCF 35
EV/EBITDA 12.61
ACT.DE Per share dataACT.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

ACT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of ACT may justify a higher PE ratio.
A more expensive valuation may be justified as ACT's earnings are expected to grow with 18.99% in the coming years.
PEG (NY)1.49
PEG (5Y)1.01
EPS Next 2Y15.49%
EPS Next 3Y18.99%

4

5. Dividend

5.1 Amount

ACT has a Yearly Dividend Yield of 1.27%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.04, ACT is paying slightly less dividend.
With a Dividend Yield of 1.27, ACT pays less dividend than the S&P500 average, which is at 2.38.
Industry RankSector Rank
Dividend Yield 1.27%

5.2 History

The dividend of ACT has a limited annual growth rate of 6.00%.
Dividend Growth(5Y)6%
Div Incr Years5
Div Non Decr Years5
ACT.DE Yearly Dividends per shareACT.DE Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

31.40% of the earnings are spent on dividend by ACT. This is a low number and sustainable payout ratio.
The dividend of ACT is growing, but earnings are growing more, so the dividend growth is sustainable.
DP31.4%
EPS Next 2Y15.49%
EPS Next 3Y18.99%
ACT.DE Yearly Income VS Free CF VS DividendACT.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M
ACT.DE Dividend Payout.ACT.DE Dividend Payout, showing the Payout Ratio.ACT.DE Dividend Payout.PayoutRetained Earnings

ALZCHEM GROUP AG

FRA:ACT (9/17/2025, 5:29:40 PM)

142.2

+2.4 (+1.72%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-30 2025-07-30
Earnings (Next)10-30 2025-10-30
Inst Owners35.03%
Inst Owner ChangeN/A
Ins Owners40.2%
Ins Owner ChangeN/A
Market Cap1.45B
Analysts81.82
Price Target161.52 (13.59%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.27%
Yearly Dividend1.2
Dividend Growth(5Y)6%
DP31.4%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)18.16%
PT rev (3m)33.25%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)2.12%
EPS NY rev (3m)2.12%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.5%
Revenue NY rev (3m)-0.66%
Valuation
Industry RankSector Rank
PE 24.9
Fwd PE 20.93
P/S 2.61
P/FCF 35
P/OCF 12.86
P/B 6.66
P/tB 6.77
EV/EBITDA 12.61
EPS(TTM)5.71
EY4.02%
EPS(NY)6.79
Fwd EY4.78%
FCF(TTM)4.06
FCFY2.86%
OCF(TTM)11.06
OCFY7.78%
SpS54.57
BVpS21.35
TBVpS20.99
PEG (NY)1.49
PEG (5Y)1.01
Profitability
Industry RankSector Rank
ROA 10.48%
ROE 26.66%
ROCE 19.03%
ROIC 13.72%
ROICexc 16.02%
ROICexgc 16.17%
OM 15.34%
PM (TTM) 10.43%
GM 65.74%
FCFM 7.45%
ROA(3y)8.81%
ROA(5y)7.86%
ROE(3y)22.87%
ROE(5y)25.91%
ROIC(3y)12.06%
ROIC(5y)10.63%
ROICexc(3y)13.35%
ROICexc(5y)11.55%
ROICexgc(3y)13.5%
ROICexgc(5y)11.66%
ROCE(3y)16.73%
ROCE(5y)14.74%
ROICexcg growth 3Y25.57%
ROICexcg growth 5Y18.04%
ROICexc growth 3Y25.41%
ROICexc growth 5Y17.9%
OM growth 3Y17.53%
OM growth 5Y12.4%
PM growth 3Y14.29%
PM growth 5Y15.31%
GM growth 3Y2.01%
GM growth 5Y1.44%
F-Score7
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 1.15
Debt/EBITDA 0.36
Cap/Depr 270.53%
Cap/Sales 12.82%
Interest Coverage 42.05
Cash Conversion 100.91%
Profit Quality 71.41%
Current Ratio 2.84
Quick Ratio 1.73
Altman-Z 4.76
F-Score7
WACC7.1%
ROIC/WACC1.93
Cap/Depr(3y)118.98%
Cap/Depr(5y)119.68%
Cap/Sales(3y)5.65%
Cap/Sales(5y)6.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.65%
EPS 3Y25.02%
EPS 5Y24.6%
EPS Q2Q%10.81%
EPS Next Y16.75%
EPS Next 2Y15.49%
EPS Next 3Y18.99%
EPS Next 5Y19.5%
Revenue 1Y (TTM)1.03%
Revenue growth 3Y9.49%
Revenue growth 5Y8.06%
Sales Q2Q%4.91%
Revenue Next Year2.89%
Revenue Next 2Y6.03%
Revenue Next 3Y8.49%
Revenue Next 5Y6.02%
EBIT growth 1Y19.3%
EBIT growth 3Y28.68%
EBIT growth 5Y21.47%
EBIT Next Year48.64%
EBIT Next 3Y26.44%
EBIT Next 5Y19.11%
FCF growth 1Y37.04%
FCF growth 3Y62.42%
FCF growth 5Y94.14%
OCF growth 1Y113.41%
OCF growth 3Y34.7%
OCF growth 5Y19.23%